We would love to hear your thoughts about our site and services, please take our survey here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
26 trades showing elsewhere
185k buys
49k sells
At the moment you can buy 10000 TMTA for £1590 and buy 7500 BELL for £1940. If the 3 for 4 deal goes through then the TMTA holders would swap their 10k for 7.5k BELL.
Not a bad exchange and TMTA is also asset backed at 17.25p cash per share.
The rising BELL price on nil trades would theoretically indicate that a deal is imminent?? As TMTA shareholders are accepting on a 3 BELL for 4 TMTA basis and BELL shares were higher at the time then this has to rise to secure the risk/reward. If due digence is indicating that this is an excellent deal then MMs are raising the price on nil trades as the deal is signaled for later in the month. Just logical speculation obviously but it does explain the anomalous upswing here as risk reward shifts. TMTA is still the best avenue for entry IMO and yet no movement there.....yet??
It upsets me I couldn’t draw you in
The force is strong in this one
Theboyg - At a guess, there must be someone in the background buying, snuffling away, but only wanting to pay the bare minimum – trouble is, as nobody seems to want to sell, and price creeping.
I suppose one of the new holders may sell another few lumps. Maybe it’s their business to make a quick 20% buck, short term and move on. Perhaps it’s not their business to stick around long term and make money from the actual business itself? Nothing wrong with that, each to their own..Who knows, maybe some late reporting coming up?
Saw your comments 31st December at the time – a nice cheery end to the year – TBH, I couldn’t be bothered to rise to the bait, poured myself another sherry instead and passed out!!
Happy New Year by the way!
Excellent new evidence to confirm that I have no idea about trading shares whatsoever
Nothing showing
Up 10%
That would appear a sensible approach and would also appear to be going quite well ?
It seems highly likely that the delay in the TMTA takeover (ie an instant non-dilutive cash injection of c£4.5m) is dependent on TMTA doing due diligence to answer your exact concerns. Essentially Belluscura is sitting on a huge potential market and confirmation of production and gear up will cement the deal. The cash is vital. TMTA with its own NAV well above current MCap appears to be the best entry gate to BELL. It gives the potential without the risk. The only possible downside is if the deal does not proceed but that would mean that BELL would have to dilute existing holders by obtaining funding elsewhere at high interest rates. This is an interesting conundrum as the deal with TMTA looks increasingly appealing to those buying TMTA as BELL price rises. Novel.
They have 6500 to make
My guess is they have made close to none despite 2,500,000 being made available outside of this deal (or thereabouts)
Not a single explanation of numbers. Without the money they are dead. The 2,500,000 seems to have done little.
You know it’s bad news because they publish all good news immediately and we are the last to hear of bad news
Not a single number hit. ‘Trebled’ direct to consumer. True it will be. But is that one unit to three units….
Literally naff all news of any substance other than more people to sell to.
Not a lot of good with naff all to sell. Last year’s numbers were lies. The total income was nothing close to the ‘out the door or soon to be out door’ numbers they stated yet it seemed to bother nobody on this board.
And nothing seemingly produced in three months worth any sort of mention
The next news will be the deal is off…. Or that they want more for their money
Either way the delay has certainly slowed or stopped production to almost zilch
Now they have a new sieve??? Makes it last so much longer. So money on inventory wasted… more time wasted…. And a new improved product to make when old one wasn’t being made much anyway.
They have them over a barrel! They will need another refinance even if this deal goes through.
Delay and excuse…. And don’t believe anything until you next have numbers
Actual numbers . Not 5000 out door or soon to be out door. Just want to hear how many made and how many paid for
The rest is noise
So you can tip this share all you like…. If it don’t head north from here it’s dead anyway… but announcements can’t be trusted until they are confirmed and numbers follow
Appalling comms from this company which tells you why they are here in the first place
I’m here to get my money back
So no digging me out. I’m here… but can someone actually enlighten the shareholders please. The delay….. what is happening and why the hell is there no news
Happy new year to all
Logic says to invest in TMTA with minute overheads and 17.15p a share cash on deposit assets as opposed to Belluscura needing cash to meet demand.
The offer of 3 Belluscura shares for 4 TMTA initially valued TMTA at 21p share which was a decent risk premium. The fall in BELL to 22p means that each TMTA is only being valued at 16.5p which is laughably less than its NAV.
I'm pretty sure that the offer doc delay is due to TMTA doing its due diligence and wanting to see concrete evidence of progress and sales. Once that has been established then the transaction should quickly follow.
Same bloke…. Believes what he reads… but he’s right if the make as many devices as they do excuses
Belluscura is one of the Top 20 ideas for 2024:
https://open.substack.com/pub/theoakbloke/p/happy-christmas-reader
On Christmas Eve the Times reported that GSK looking to spend billions on respiratory health. Step forward BELL with the best COPD product in the world!
Bah
Theboyg – My niece sent this to me, but when I watched it, for some reason I thought it was more appropriate to you!!
Have a great Christmas – definitely signing off now with every intent on over indulging in both food and drink!!
https://www.youtube.com/watch?v=Ch3NoKDdzCg
Merry Christmas Agricore
This chap believes what he reads!
This is Bell. Nothing is what it seems! They will need another fund raise. They are 2 quarters behind almost …. and not doing much other than getting larger population to sell to
I hope not but they are disappointing with the only thing that matters…. Sales
Bob ‘I like to meet my numbers’ has yet to meet a single one…. and now cannot even make a deadline
A deadline that has stalled all production…. Ergo cash…. Ergo cashflow
Produced nothing, likely because the have no cash despite 2.5 million being made available in October and 6500 units that need making… now waiting for this agreement and cash to be available to make stuff to sell to the 1.2 trillion people with COPD and COVID and all kinds of breathing difficulties in ever expanding markets
Delay… excuse…. Delay…. Excuse
You have enough markets to sell to
Enough people who need them
Right now it’s like wishing for a blo@dy unicorn
Just make the damn things
Merry Christmas to all BELL-ies! A brighter 2024 ahead.
https://open.substack.com/pub/theoakbloke/p/ding-dong-news-from-bell
So hedge your bets and still have the security of cash exceeding MCap on deposit with TMTA. They are doing the due diligence for shareholders which covers the risk and enhances the upside which ,"looks significant"
But deal must go through! I think they will go for a better deal! Why is there a delay?
Someone is holding it up! It’s clear they have done close to zip in last three months. Marketing and something else paused. So I guess zero cash and no loans ready if this falls through
No money equals desperate = don’t ask don’t get better deal
They have no plan b? So they have them by b*lls if any of this is a possibility
Exploit the difference!
£2000 will currently buy, with costs,
12456 TMTA or 9068 BELL
With TMTA you are induring your risk with assets worth 17.25p a share versus 15.9p to buy.
The merger/takeover of BELL and TMTA is on a 3 BELL for every 4 TMTA
12456 divided by 4 is 3114
Multiplied by 3 is 9342 BELL.
So cheaper to buy TMTA and its got 17.25p per share assets underpinning it.
It was £2500
Probably the new case/seal has upped price and made it’s longevity improve
Pretty pleased with this update. Things seem pretty much on track for 2024. Good that the unit price of the new product is $3000. Didn't realise it was so high.
4 months on
Not a single word on production
They had access to £3million in October but still we hear nothing
RNS from August is below
But if they can’t get their act together by end of H1 2024 they are finished.
The must produce and sell, produce and sell. I assume cash is the problem and I don’t know why!
Still don’t understand with 6500 ordered why you don’t get your loan. Pay the 10% for the six months you need it… or 12 or 18 months…but you have wasted almost half a year allowing something that had the appearance of being unique, being left dusty on shelves
Come on VOX. Get an interview in and ask some questions
Remember Bob likes to hit his numbers. I assume he was talking darts
Pre-commercial launch orders by leading online retailers and medical equipment providers demonstrate the scale of the demand for this transformational product
LONDON, U.K. AND PLANO, TX, U.S. (16 August 2023). Belluscura plc (AIM: BELL), a leading medical device developer focused on lightweight and portable oxygen enrichment technology, announces that it has received purchase orders for over 6,500 of its next-generation DISCOV-R portable oxygen concentrator. This represents approximately $15 million of potential revenue to the Company, with initial production of the DISCOV-R expected to begin by the end of this quarter.
Following the pre-market launch of DISCOV-R and a patient usability study in June 2023, the Company plans a controlled roll out of the DISCOV-R this autumn and into 2024 to meet growing demand for the device amid substantial interest from medical device distributors, retailers, patients and durable medical equipment (DME) providers, among others.
The DISCOV-R is expected to be the world's first ambulatory two litre continuous flow, eight level pulse dose portable oxygen concentrator when it is released. With the ability to produce two litres of continuous flow and maximum single pulse dose volumes exceeding 110ml, the Company believes that the DISCOV-R will be covered by both CMS E1390 (stationary) and E1392 (portable) reimbursement codes, making the DISCOV-R a better financial option for the thousands of homecare oxygen providers. It will also produce nearly three times as much oxygen by weight than its dual flow competitors.
The recent purchase orders follow the signing of several distribution agreements with medical device distributors and other home healthcare providers, including a distribution agreement with a division of McKesson, one of the largest distributors of pharmaceuticals and medical devices in North America, earlier this month and a marketing agreement with GoodRx®, a leading digital healthcare platform, in February 2023. The Company has received multiple additional requests from leading oxygen homecare providers in the US to distribute the DISCOV-R.
The Company will update the market later this year as it plans its controlled roll out of the DISCOV
Now then. We did have 6500 discover-r units ordered!
Three months to make them and not a word about how many made in three (2.5months). Literally not a word
Surely you let people know how many you have made! It looks like none! None. 2000 should have been out door and money banked!
No further orders which must be a worry! In essence everything delayed and no reason given. They had money in October to produce and manufacture
Why nothing
Happy to tell us DTC has tripled! Awesome. From 1 to 3 units or from 5000 to 15000
They just can’t seem to keep things consistent in their messages
Just gives us some numbers
The absence of numbers is clearly an indication that they are hiding the worst
And they had millions in inventory.millions.
China could be their salvation. Doing v little elsewhere. But 10 months delay. Just enough time to have perfected a ripped off cheaper version
Ok… that’s one too many
But can anyone here tell me why 6500 ordered units are not well into production????